48 research outputs found

    Method for the Calculation of DPA in the Reactor Pressure Vessel of Atucha II

    Get PDF
    One of the limiting factors of the life of a nuclear power plant (NPP) is the state of the reactor pressure vessel (RPV). Embrittlement is the most important effect affecting RPV aging. The irradiation with neutrons, especially fast neutrons, is the primary cause of this embrittlement. NPP safe operation requires to ensure RPV integrity over its lifetime, threatened by the neutron radiation-induced embrittlement. In this paper, we identify the areas where the RPV neutron radiation is maximum and perform calculations of the displacement-per-atom (DPA) rate in those areas using the MCNP5 code. It was determined that the maximum DPA rate in the RPV wall with fresh fuel element (FE) is 3.76(3) × 10-12 s-1, it takes place in front of FEs BA42 and BL43, and it is symmetrical about the central channel, LG04, and LH03

    Stereodivergent Synthesis of Enantioenriched 4-Hydroxy-2- cyclopentenones

    Get PDF
    Protected 4-hydroxycyclopentenones (4-HCPs) constitute an important class of intermediates in chemical synthesis. A route to this class of compound has been developed. Key steps include Noyori reduction (which establishes the stereochemistry of the product), ring-closing metathesis, and simple functional group conversions to provide a set of substituted 4-HCPs in either enantiomeric form

    Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes

    Get PDF
    There is a recognized need for new treatment options for type 2 diabetes mellitus (T2DM). Recovery of glucose from the glomerular filtrate represents an important mechanism in maintaining glucose homeostasis and represents a novel target for the management of T2DM. Recovery of glucose from the glomerular filtrate is executed principally by the type 2 sodium-glucose cotransporter (SGLT2). Inhibition of SGLT2 promotes glucose excretion and normalizes glycemia in animal models. First reports of specifically designed SGLT2 inhibitors began to appear in the second half of the 1990s. Several candidate SGLT2 inhibitors are currently under development, with four in the later stages of clinical testing. The safety profile of SGLT2 inhibitors is expected to be good, as their target is a highly specific membrane transporter expressed almost exclusively within the renal tubules. One safety concern is that of glycosuria, which could predispose patients to increased urinary tract infections. So far the reported safety profile of SGLT2 inhibitors in clinical studies appears to confirm that the class is well tolerated. Where SGLT2 inhibitors will fit in the current cascade of treatments for T2DM has yet to be established. The expected favorable safety profile and insulin-independent mechanism of action appear to support their use in combination with other antidiabetic drugs. Promotion of glucose excretion introduces the opportunity to clear calories (80–90 g [300–400 calories] of glucose per day) in patients that are generally overweight, and is expected to work synergistically with weight reduction programs. Experience will most likely lead to better understanding of which patients are likely to respond best to SGLT2 inhibitors, and under what circumstances

    Anorexia, Oral Health and Antioxidant Salivary System: A Clinical Study on Adult Female Subjects.

    Get PDF
    The aim of this study was to compare the oral health status and salivary antioxidant system between patients diagnosed with anorexia nervosa (AN) and healthy controls. A total of 25 female AN patients and 25 matched healthy controls were enrolled. Clinical parameters and saliva samples were collected for each patient. Two questionnaires to investigate oral health and hygiene were administered. Superoxide Dismutase (SOD) activity and High Reactive Oxygen Species (hROS) were evaluated. Salivary concentration of SOD was significantly higher in subjects with AN compared with control group (1.010 ± 0.462 vs. 0.579 ± 0.296 U/mL; p = 0.0003). No significant differences between groups were identified for hROS (233.72 ± 88.27 vs. 199.49 ± 74.72; p = 0.15). Data from questionnaires indicated that, although most of the patients recognized the oral hygiene importance in maintaining a good oral health, more than half of them had poor oral hygiene. Altered biochemical composition of saliva in patients with AN could be interpreted as an effective defence mechanism against oxidative stress. Moreover, despite the discrepancy between clinical findings and perception of the oral health in AN population arose, the quality of life of these patients appears not to be significantly affected by their dental condition
    corecore